Home / newsitem / Avista Capital Partners Completes Sale of Arcadia Consumer Healthcare

Avista Capital Partners Completes Sale of Arcadia Consumer Healthcare

NEW YORKSept. 10, 2021 — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced the completion of its sale of Arcadia Consumer Healthcare, Inc. (“Arcadia”), a recognized leader in the consumer healthcare market for over-the-counter (“OTC”) medicines and premium vitamins and nutritional supplements, to Bansk Group. The transaction was first announced on August 9, 2021.

Avista acquired Arcadia’s predecessor Kramer Laboratories, Inc. in 2018. Kramer’s product platform included highly efficacious OTC foot care and specialty cough treatments to help consumers take care of themselves every day. Today, through M&A and investments in innovative new self-care product categories, Arcadia is a leading platform of consumer healthcare products, including premium vitamin and nutritional supplements, and OTC medicines in the therapeutic hair care, foot care, digestive health and specialty cough categories.

Rob Girardi, Partner at Avista, said, “Arcadia’s transformation during Avista’s investment period began with the rebranding of Kramer Laboratories in 2019 and accelerated with the expansion of its product base to include brands that help consumers thrive. With an experienced team and a strong portfolio of existing assets with an exciting pipeline of new ones, the company is well-positioned to execute against the next phase of its growth plan.”

Houlihan Lokey served as the exclusive financial advisor to Arcadia and assisted in structuring and negotiating the transaction on its behalf. Ropes & Gray served as Arcadia’s legal advisor.

About Avista Capital Partners

Founded in 2005, Avista Capital is a leading New York-based private equity firm with nearly $8 billion invested in 40 growth-oriented healthcare businesses globally. Avista partners with businesses that feature strong management teams, stable cash flows and robust growth prospects – investing in the medical devices and technologies, pharmaceuticals, outsourced pharmaceutical services, healthcare technology, healthcare distribution, and consumer-driven healthcare sectors. Avista’s Operating Executives and Advisors are an integral part of the team, providing strategic insight, operational oversight and senior counsel, which helps drive growth and performance, while fostering sustainable businesses and creating long-term value for all stakeholders. For more information, visit www.avistacap.com.

About Arcadia Consumer Healthcare

Arcadia Consumer Healthcare, formerly known as Kramer Laboratories, is a recognized leader in the consumer healthcare market for over-the-counter medicines and premium vitamins and nutritional supplements. For over 35 years, the company has been delivering innovative healthcare products to help consumers self-treat their everyday problems. Arcadia’s flagship brands include Nizoral®, a highly efficacious therapeutic dandruff shampoo brand, NATURELO®, a leader in premium vitamins and nutritional supplements, Kaopectate®, a leader in treatment of diarrhea and upset stomach,  Fungi-Nail®, a specialty anti-fungal product formulated with a clinically proven ingredient that cures and prevents fungal infections, and Opti-NailTM, a new and unique cosmetic fungal nail repair brand. Additional portfolio brands include HC Max™, a maximum strength anti-fungal remedy, and Safetussin®, a pharmacist-developed cough relief solution for adults suffering from diabetes and/or high blood pressure. Arcadia Consumer Healthcare’s products are sold online and in over 60,000 stores nationwide, including major drug, food and mass merchandiser outlets. Learn more at www.arcadiach.com.